NCT05699031 Shoulder Prosthesis Telerehab Care Trial
| NCT ID | NCT05699031 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | SHOULDER ARTHROPLASTY |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-03-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2023-03-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the rehabilitation by use of a smartphone-app with the usual care of physical therapy in patients, 60 years and older, who underwent a primary shoulder arthroplasty. The main questions it aims to answer are: * is the outcome of rehabilitation with the app as good as the usual care? * is the outcome for both types of shoulder arthroplasty similar? * what is the usability of the app?. Participants will * have treatment according to the group they are allocated to * fill in questionnaires at specific moments during the rehabilitation stage (0 - 3 months ) and at 1 year post-surgery
Eligibility Criteria
Inclusion Criteria: * 60 years and older * primary total shoulder arthroplasty (anatomical and reverse) * osteoarthritis, cuff tear arthropathy, pseudoparalysis * return home after discharge from hospital * no brace after surgery * sufficient verbal and written comprehension * hospitalization insurance Exclusion Criteria: * revision arthroplasty * arthroplasty for fracture or tumor * neurological disease (parkinson, stroke, ...) * no access to smartphone, tablet or internet connectivity
Contact & Investigator
Alexander Van Tongel, PhD
PRINCIPAL INVESTIGATOR
University Ghent, University Hospital Ghent
Frequently Asked Questions
Who can join the NCT05699031 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying SHOULDER ARTHROPLASTY. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05699031 currently recruiting?
Yes, NCT05699031 is actively recruiting participants. Contact the research team at dominiek.vandenbosch@ugent.be for enrollment information.
Where is the NCT05699031 trial being conducted?
This trial is being conducted at Ghent, Belgium.
Who is sponsoring the NCT05699031 clinical trial?
NCT05699031 is sponsored by University Hospital, Ghent. The principal investigator is Alexander Van Tongel, PhD at University Ghent, University Hospital Ghent. The trial plans to enroll 120 participants.